Franck G. Sturtz

Limoges, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Polyvalent immunoglobulin therapy: preclinical evidence and potential for treating chemotherapy-induced peripheral neuropathy.

Polyvalent immunoglobulin therapy: preclinical evidence and potential for treating chemotherapy-induced peripheral neuropathy.

Journal: Expert opinion on investigational drugs

Published: June 27, 2025

Neuroprotective Effect of Mas Activation by BIO101 in Vincristine-Induced Small Fiber Neuropathy.

Neuroprotective Effect of Mas Activation by BIO101 in Vincristine-Induced Small Fiber Neuropathy.

Journal: Journal of the peripheral nervous system : JPNS

Published: February 20, 2025

TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023.

TTR Gene Screening Since the Advent of Biotherapies in France: A Nationwide Retrospective Survey Between 2018 and 2023.

Journal: European journal of neurology

Published: December 09, 2024

Addressing myelination disorders: Novel strategies using human 3D peripheral nerve model.

Addressing myelination disorders: Novel strategies using human 3D peripheral nerve model.

Journal: Brain research bulletin

Published: August 28, 2024

Advances in modeling the Charcot-Marie-Tooth disease: Human induced pluripotent stem cell-derived Schwann cells harboring SH3TC2 variants.

Advances in modeling the Charcot-Marie-Tooth disease: Human induced pluripotent stem cell-derived Schwann cells harboring SH3TC2 variants.

Journal: European journal of cell biology

Published: July 28, 2024

From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

Journal: Journal of tissue engineering

Published: June 10, 2024

Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategies.

Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategies.

Journal: Orphanet journal of rare diseases

Published: June 10, 2024

CRISPR Base Editing to Create Potential Charcot-Marie-Tooth Disease Models with High Editing Efficiency: Human Induced Pluripotent Stem Cell Harboring SH3TC2 Variants.

CRISPR Base Editing to Create Potential Charcot-Marie-Tooth Disease Models with High Editing Efficiency: Human Induced Pluripotent Stem Cell Harboring SH3TC2 Variants.

Journal: Biomedicines

Published: May 28, 2024

Serum S100B Level in the Management of Pediatric Minor Head Trauma: A Randomized Clinical Trial.

Serum S100B Level in the Management of Pediatric Minor Head Trauma: A Randomized Clinical Trial.

Journal: JAMA network open

Published: March 19, 2024

Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.

Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.

Journal: Pharmaceutics

Published: December 07, 2023

Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.

Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 05, 2023

Improvement of Charcot-Marie-Tooth Phenotype with a Nanocomplex Treatment in Two Transgenic Models of CMT1A.

Improvement of Charcot-Marie-Tooth Phenotype with a Nanocomplex Treatment in Two Transgenic Models of CMT1A.

Journal: Biomaterials research

Published: November 11, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026